DSpace Repository

Cancer Vaccines [electronic resource] / edited by Natalia Savelyeva, Christian Ottensmeier.

Show simple item record

dc.contributor.author Savelyeva, Natalia. editor.
dc.contributor.author Ottensmeier, Christian. editor.
dc.contributor.author SpringerLink (Online service)
dc.date.accessioned 2017-12-01T05:59:04Z
dc.date.available 2017-12-01T05:59:04Z
dc.date.created 2017.
dc.date.issued 2017
dc.identifier.isbn 9783319239101
dc.identifier.uri http://dspace.conacyt.gov.py/xmlui/handle/123456789/15401
dc.description VII, 210 p.
dc.description.abstract This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.
dc.description.tableofcontents New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines – Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.
dc.language eng
dc.publisher Cham : Springer International Publishing : Imprint: Springer, 2017.
dc.relation.ispartofseries Springer eBooks
dc.relation.ispartofseries Current Topics in Microbiology and Immunology, 0070-217X ; 405
dc.relation.ispartofseries Current Topics in Microbiology and Immunology, 0070-217X ; 405
dc.relation.uri http://cicco.idm.oclc.org/login?url=http://dx.doi.org/10.1007/978-3-319-23910-1
dc.subject Medicine.
dc.subject Cancer research.
dc.subject Immunology.
dc.subject Vaccines.
dc.subject Biomedicine.
dc.subject Cancer Research.
dc.subject Immunology.
dc.subject Vaccine.
dc.subject.ddc 614.5999 23
dc.subject.lcc RC261-271
dc.subject.other Biomedical and Life Sciences (Springer-11642)
dc.title Cancer Vaccines [electronic resource] / edited by Natalia Savelyeva, Christian Ottensmeier.
dc.type text
dc.identifier.doi 10.1007/978-3-319-23910-1
dc.description.edition 1st ed. 2017.
dc.identifier.bib 978-3-319-23910-1
dc.format.rdamedia computer
dc.format.rdacarrier online resource
dc.format.rda text file PDF

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account